Impact of Perfluorooctane Sulfonate on Reproductive Ability of Female Mice through Suppression of Estrogen Receptor α-Activated Kisspeptin Neurons.
Wang. Xiaoli X; Bai. Yingyang Y; Tang. Chuanfeng C; Cao. Xinyuan X; Chang. Fei F; Chen. Ling L
Key Findings
- Oral PFOS (10 mg/kg) lengthens the non‑fertile phase (diestrus) and lowers progesterone, LH, and GnRH in female mice.
- PFOS suppresses estrogen receptor‑α‑driven activation of AVPV kisspeptin neurons, which are crucial for the LH surge that triggers ovulation.
- Administering kisspeptin‑10 restores the LH surge, normalizes hormone levels, and corrects the reproductive cycle disruption caused by PFOS.
Practical Outcomes
- For biohackers, the takeaway is to minimize exposure to PFOS (found in some non‑stick cookware, stain‑resistant fabrics, and firefighting foams) to protect reproductive health. While kisspeptin‑10 shows promise in reversing PFOS‑induced fertility issues in mice, it is not yet a safe or approved supplement for human use, so it remains a research finding rather than a ready‑to‑use protocol.
Summary
The study shows that a common industrial chemical, PFOS, can mess up female mouse reproductive cycles by blocking estrogen‑driven activation of kisspeptin neurons in the brain. Giving the peptide kisspeptin‑10 to these mice fixed the hormone surge needed for ovulation, suggesting the peptide can bypass the PFOS‑induced block.
Abstract
Perfluorooctane sulfonate (PFOS) is used extensively in industrial and household applications. High exposure to PFOS has been associated with increased odds of irregular and long menstrual cycles in women. However, the underlying mechanisms remain to be elucidated. Herein, we show that adult female mice appeared prolongation of diestrus and reduction of corpora luteum within a week of oral administration of PFOS (10 mg/kg), which are associated with decreases in the levels of serum progesterone, LH and hypothalamic GnRH. The number of AVPV-kisspeptin neurons and the AVPV-kisspeptin expression were increased in proestrus mice or OVX-mice treated with high-dose estradiol benzoate (0.05 mg/kg), which were suppressed by the administration of PFOS. The administration of PFOS or GPR54 antagonist P234 prevented the generation of LH-surge in OVX-mice treated with high-dose E2. In hypothalamic slices incubated in 100 nM E2 for 4 h, the AVPV-kisspeptin expression was significantly enhanced, which was inhibited by PFOS in a dose-dependent manner or estrogen receptor α (ERα) antagonist MPP, but not ERβ antagonist PHTPP. The incubation of ERα agonist PPT rather than ERβ agonist DPN could increase the level of AVPV-kisspeptin expression, which was sensitive to the treatment with PFOS. The administration of GPR54 agonist kisspeptin-10 in PFOS-mice could correct the prolongation of diestrus and reduction of corpora luteum, and recover the LH-surge and the levels of LH and GnRH. The results indicate that exposure to PFOS suppressed ERα-induced activation of AVPV-kisspeptin neurons leads to diestrus prolongation and ovulation reduction.
Study Information
pubmed
2018
2018-10-01T00:00:00.000Z
10.1093/toxsci/kfy167
36
58